Annual Cash & Cash Equivalents
$12.14 M
-$22.77 M-65.23%
December 31, 2023
Summary
- As of February 8, 2025, AXDX annual cash & cash equivalents is $12.14 million, with the most recent change of -$22.77 million (-65.23%) on December 31, 2023.
- During the last 3 years, AXDX annual cash & cash equivalents has fallen by -$23.64 million (-66.08%).
- AXDX annual cash & cash equivalents is now -89.93% below its all-time high of $120.58 million, reached on December 31, 2015.
Performance
AXDX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$19.69 M
+$11.10 M+129.29%
September 30, 2024
Summary
- As of February 8, 2025, AXDX quarterly cash and cash equivalents is $19.69 million, with the most recent change of +$11.10 million (+129.29%) on September 30, 2024.
- Over the past year, AXDX quarterly cash and cash equivalents has stayed the same.
- AXDX quarterly cash and cash equivalents is now -84.48% below its all-time high of $126.85 million, reached on March 31, 2018.
Performance
AXDX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
AXDX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.2% | 0.0% |
| 3 y3 years | -66.1% | 0.0% |
| 5 y5 years | -81.7% | 0.0% |
AXDX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.6% | at low | -50.6% | +329.8% |
| 5 y | 5-year | -80.1% | at low | -67.7% | +329.8% |
| alltime | all time | -89.9% | +4184.5% | -84.5% | >+9999.0% |
Accelerate Diagnostics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $19.69 M(+129.3%) |
| Jun 2024 | - | $8.59 M(-41.2%) |
| Mar 2024 | - | $14.61 M(+20.3%) |
| Dec 2023 | $12.14 M(-65.2%) | $12.14 M(-39.8%) |
| Sep 2023 | - | $20.16 M(-31.1%) |
| Jun 2023 | - | $29.28 M(-0.4%) |
| Mar 2023 | - | $29.41 M(-15.7%) |
| Dec 2022 | $34.91 M(-12.5%) | $34.91 M(-10.5%) |
| Sep 2022 | - | $38.99 M(+751.1%) |
| Jun 2022 | - | $4.58 M(-66.4%) |
| Mar 2022 | - | $13.65 M(-65.8%) |
| Dec 2021 | $39.90 M(+11.5%) | $39.90 M(+11.7%) |
| Sep 2021 | - | $35.73 M(-19.9%) |
| Jun 2021 | - | $44.58 M(+4.3%) |
| Mar 2021 | - | $42.73 M(+19.4%) |
| Dec 2020 | $35.78 M(-41.4%) | $35.78 M(+32.4%) |
| Sep 2020 | - | $27.03 M(-42.9%) |
| Jun 2020 | - | $47.37 M(+20.0%) |
| Mar 2020 | - | $39.49 M(-35.3%) |
| Dec 2019 | $61.01 M(-7.9%) | $61.01 M(-34.3%) |
| Sep 2019 | - | $92.94 M(+6.3%) |
| Jun 2019 | - | $87.47 M(+16.1%) |
| Mar 2019 | - | $75.31 M(+13.7%) |
| Dec 2018 | $66.26 M(+132.4%) | $66.26 M(+7.5%) |
| Sep 2018 | - | $61.62 M(-7.8%) |
| Jun 2018 | - | $66.81 M(-47.3%) |
| Mar 2018 | - | $126.85 M(+344.9%) |
| Dec 2017 | $28.51 M(+48.2%) | $28.51 M(-17.2%) |
| Sep 2017 | - | $34.43 M(-45.0%) |
| Jun 2017 | - | $62.61 M(+531.3%) |
| Mar 2017 | - | $9.92 M(-48.5%) |
| Dec 2016 | $19.24 M(-84.0%) | $19.24 M(-33.0%) |
| Sep 2016 | - | $28.73 M(-23.4%) |
| Jun 2016 | - | $37.52 M(-47.9%) |
| Mar 2016 | - | $72.03 M(-40.3%) |
| Dec 2015 | $120.58 M(+125.1%) | $120.58 M(+378.7%) |
| Sep 2015 | - | $25.19 M(-28.5%) |
| Jun 2015 | - | $35.23 M(-25.7%) |
| Mar 2015 | - | $47.39 M(-11.5%) |
| Dec 2014 | $53.56 M(+78.4%) | $53.56 M(-7.4%) |
| Sep 2014 | - | $57.85 M(-11.3%) |
| Jun 2014 | - | $65.21 M(+149.5%) |
| Mar 2014 | - | $26.14 M(-12.9%) |
| Dec 2013 | $30.03 M(+148.8%) | $30.03 M(-10.2%) |
| Sep 2013 | - | $33.45 M(+23.1%) |
| Jun 2013 | - | $27.17 M(-7.1%) |
| Mar 2013 | - | $29.26 M(+121.7%) |
| Dec 2012 | $12.07 M(-15.4%) | - |
| Oct 2012 | - | $13.20 M(-7.5%) |
| Jul 2012 | $14.26 M(+2327.4%) | $14.26 M(+6596.3%) |
| Apr 2012 | - | $213.00 K(-58.5%) |
| Jan 2012 | - | $513.00 K(-12.3%) |
| Dec 2011 | $587.60 K(-24.3%) | - |
| Oct 2011 | - | $585.00 K(-24.6%) |
| Jul 2011 | $775.90 K(+173.9%) | $775.90 K(+108.4%) |
| Apr 2011 | - | $372.30 K(-12.5%) |
| Jan 2011 | - | $425.30 K(+91.1%) |
| Oct 2010 | - | $222.50 K(-21.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2010 | $283.30 K(-67.1%) | $283.30 K(+70.6%) |
| Apr 2010 | - | $166.10 K(+52.5%) |
| Jan 2010 | - | $108.90 K(-76.9%) |
| Oct 2009 | - | $470.50 K(-45.4%) |
| Jul 2009 | $862.10 K(-30.1%) | $862.10 K(-11.9%) |
| Apr 2009 | - | $978.90 K(-0.8%) |
| Jan 2009 | - | $986.90 K(-8.7%) |
| Oct 2008 | - | $1.08 M(-12.3%) |
| Jul 2008 | $1.23 M(-11.5%) | $1.23 M(-3.4%) |
| Apr 2008 | - | $1.28 M(+45.3%) |
| Jan 2008 | - | $878.60 K(-14.5%) |
| Oct 2007 | - | $1.03 M(-26.3%) |
| Jul 2007 | $1.39 M(-53.6%) | $1.39 M(-22.6%) |
| Apr 2007 | - | $1.80 M(-14.3%) |
| Jan 2007 | - | $2.10 M(-17.1%) |
| Oct 2006 | - | $2.54 M(-15.6%) |
| Jul 2006 | $3.00 M(-46.0%) | $3.00 M(-14.6%) |
| Apr 2006 | - | $3.52 M(-15.9%) |
| Jan 2006 | - | $4.18 M(-15.0%) |
| Oct 2005 | - | $4.92 M(-11.5%) |
| Jul 2005 | $5.56 M(-23.1%) | $5.56 M(-5.7%) |
| Apr 2005 | - | $5.90 M(-8.2%) |
| Jan 2005 | - | $6.42 M(-5.7%) |
| Oct 2004 | - | $6.82 M(-5.8%) |
| Jul 2004 | $7.23 M(-17.0%) | $7.23 M(-3.7%) |
| Apr 2004 | - | $7.51 M(-3.7%) |
| Jan 2004 | - | $7.80 M(-4.5%) |
| Oct 2003 | - | $8.17 M(-6.2%) |
| Jul 2003 | $8.71 M(+0.9%) | $8.71 M(+0.2%) |
| Apr 2003 | - | $8.69 M(-5.3%) |
| Jan 2003 | - | $9.18 M(+6.2%) |
| Oct 2002 | - | $8.64 M(+0.1%) |
| Jul 2002 | $8.63 M(-9.4%) | $8.63 M(+0.3%) |
| Apr 2002 | - | $8.61 M(-1.0%) |
| Jan 2002 | - | $8.69 M(-4.4%) |
| Oct 2001 | - | $9.09 M(-4.5%) |
| Jul 2001 | $9.52 M(-8.1%) | $9.52 M(-2.8%) |
| Apr 2001 | - | $9.80 M(-2.2%) |
| Jan 2001 | - | $10.02 M(-3.3%) |
| Oct 2000 | - | $10.36 M(-0.0%) |
| Jul 2000 | $10.36 M(+1.0%) | $10.36 M(+0.5%) |
| Apr 2000 | - | $10.31 M(-2.4%) |
| Jan 2000 | - | $10.56 M(+0.0%) |
| Oct 1999 | - | $10.56 M(+2.9%) |
| Jul 1999 | $10.26 M(-1.4%) | $10.26 M(-0.3%) |
| Apr 1999 | - | $10.29 M(+1.2%) |
| Jan 1999 | - | $10.17 M(-4.0%) |
| Oct 1998 | - | $10.59 M(+1.8%) |
| Jul 1998 | $10.40 M(+31.6%) | $10.40 M(+1.1%) |
| Apr 1998 | - | $10.28 M(+10.7%) |
| Jan 1998 | - | $9.29 M(+14.0%) |
| Oct 1997 | - | $8.15 M(+3.1%) |
| Jul 1997 | $7.90 M(+464.3%) | $7.90 M(0.0%) |
| Apr 1997 | - | $7.90 M(-1.3%) |
| Jan 1997 | - | $8.00 M(+370.6%) |
| Oct 1996 | - | $1.70 M(+21.4%) |
| Jul 1996 | $1.40 M | $1.40 M(+27.3%) |
| Apr 1996 | - | $1.10 M(+22.2%) |
| Jan 1996 | - | $900.00 K |
FAQ
- What is Accelerate Diagnostics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Accelerate Diagnostics?
- What is Accelerate Diagnostics annual cash & cash equivalents year-on-year change?
- What is Accelerate Diagnostics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Accelerate Diagnostics?
- What is Accelerate Diagnostics quarterly cash and cash equivalents year-on-year change?
What is Accelerate Diagnostics annual cash & cash equivalents?
The current annual cash & cash equivalents of AXDX is $12.14 M
What is the all time high annual cash & cash equivalents for Accelerate Diagnostics?
Accelerate Diagnostics all-time high annual cash & cash equivalents is $120.58 M
What is Accelerate Diagnostics annual cash & cash equivalents year-on-year change?
Over the past year, AXDX annual cash & cash equivalents has changed by -$22.77 M (-65.23%)
What is Accelerate Diagnostics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AXDX is $19.69 M
What is the all time high quarterly cash and cash equivalents for Accelerate Diagnostics?
Accelerate Diagnostics all-time high quarterly cash and cash equivalents is $126.85 M
What is Accelerate Diagnostics quarterly cash and cash equivalents year-on-year change?
Over the past year, AXDX quarterly cash and cash equivalents has changed by $0.00 (0.00%)